Neoadjuvant Chemotherapy Combined With Targeted Treatment in High-risk Retroperitoneal Sarcoma
Phase 4
- Conditions
- Interventions
- First Posted Date
- 2023-05-06
- Last Posted Date
- 2023-05-12
- Lead Sponsor
- Peking University International Hospital
- Target Recruit Count
- 102
- Registration Number
- NCT05844813
- Locations
- 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
🇨🇳First Affiliated Hospital Xi'an Jiaotong University, Xi'an, Shanxi, China
🇨🇳Shanghai Zhongshan Hospital, Shanghai, Shanghai, China
Study of Sirolimus in IgG4-related Disease
- First Posted Date
- 2023-02-28
- Last Posted Date
- 2023-02-28
- Lead Sponsor
- Peking University International Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT05746689
Study of Sirolimus in Idiopathic Retroperitoneal Fibrosis
- First Posted Date
- 2019-08-06
- Last Posted Date
- 2024-04-15
- Lead Sponsor
- Peking University International Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT04047576
- Locations
- 🇨🇳
Peking University International Hospital, Beijing, Beijing, China
Precision Bypass in Patients With Moyamoya Disease
- First Posted Date
- 2018-05-04
- Last Posted Date
- 2021-03-10
- Lead Sponsor
- Peking University International Hospital
- Registration Number
- NCT03516851
- Locations
- 🇨🇳
Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing, China
🇨🇳Peking University International Hospital, Beijing, Beijing, China
© Copyright 2024. All Rights Reserved by MedPath